MarketResearchReports.com: Influence of Antibody Attributes on Clinical Success - A Technology and Coporate Benchmark Analysis New Report Launched

How do antibody characteristics impact clinical success?

The analytical report ‘Influence of Antibody Attributes on Clinical Success - A Technology and Coporate Benchmark Analysis’ evaluates the impact of a number of antibody attributes on the success rate of antibodies in clinical development. Among the antibody attributes studied  in this investigation are antibody generation technology, animal species of the parental antibody, antibody format, immunoglobulin class and isotype, target, and therapeutic area. Information from more than 500 naked recombinant monoclonal antibodies was used for this research. Antibodies which failed in clinical development were further analyzed for the reason of failure and phase in which they were discontinued. Biotech and pharmaceutical companies with a significant R&D portfolio of therapeutic antibodies were benchmarked for their antibody success rate in development and the underlying antibody attributes contributing to success.

Specific antibody attributes evaluated for their influence on success in clinical development in this research study are:

• In vitro antibody generation technologies: display technologies from CAT, Dyax, Morphosys, BioInvent, Domantis, Genentech, others;
• In vivo antibody generation technologies: chimeric, primatized, nanobodies, deimmunized, human engineered, humaneered, humanized, XenoMouse, HuMab mouse, KM mouse, VelocImmune mouse, human B-cell derived;
• Animal species of parental wild-type antibody: mouse, rat, rabbit, hamster, cynomolgus monkey, camelid;
• Target;
• Immunoglobulin (Ig) class;
• IgG isotype;

Therapeutic area of lead indication.

When discovering a new monoclonal antibody, researchers have a number of choices to make regarding antibody generation technologies as well as antibody format and immunoglobulin isotpye among other attributes. One of the basic controversies in selecting the antibody generation technolgoy is the question whether antibodies generated in vitro by display technologies are really equivalent to those generated in vivo by a competent immune system.

Typical questions in antibody R&D are:

• When selecting an in vivo system for antibody generation, are conventional in vivo systems with an animal immune system and subsequent chimerization or humanization creating the same as „modern“ transgenic animals?
• Are full length antibodies more successful than modern engineered nanobodies, scFv molecules or even domain antibodies?
• Do companies have different success rates in their antibody development portfolio?
• And, if yes, are they using different technologies than their peers which could explain the difference?
• Is there a different success rate of antibodies against the same target based on generation technologies or other attributes?
• Are there therapeutic areas with higher likelihood of successful development of antibodies than others?
• What are the main reasons for antibody failure in clinical development?
• In which phase do antibodies typically fail?

This analytical report will give you answers for many of these questions. The results of the analysis show-

•  whether and how antibody generation technologies differently impact clinical success;
• why and when antibodies fail;
• how target selection influences clinical success;
• if antibody format, class and isotype is relevant for development success;
• the antibody success rate of therapeutic areas;
• which companies are the most successful and which antibody attributes they prefer.

Spanning over 88 pages and 45 tables, “Influence of Antibody Attributes on Clinical Success - A Technology and Coporate Benchmark Analysi” report provides an overview antibody technologies and attrition rates industry analysis 2013.

For more information visit : http://www.marketresearchreports.com/la-merie-publishing/influence-antibody-attributes-clinical-success-%E2%80%93-technology-and-coporate

Find all Pharmaceuticals and Healthcare Reports under a single page.

MarketResearchReports.com: Global hospital cardiac patient monitoring devices market to reach $5.3 billion by 2019 Finds New Report

The report has 230 pages, 102 tables and figures. Whereas cardiac monitor units were initially used in newly created critical care units, now many patients with primary disease conditions other than cardiac disease also have complications that affect the heart and therefor need monitoring in other parts of the hospital.

The hospital cardiac patient monitoring industry is evolving rapidly and is becoming increasingly competitive as more parameters are monitored and integration with the electronic patient record occurs. This is the basis on which vendor share shifts, with Philips gaining share in recent years. Companies with substantial resources are poised to enter the market, probably through acquisition. Vendors are poised to face increased competition even as market consolidation occurs.

Shortness of breath is a common symptom of cardiac disease. It is frequently misdiagnosed as a respiratory symptom or ignored by patients and is not even considered a symptom. Hospital cardiac patient monitoring can detect arrhythmias and get people to treatment faster before it is too late to correct heart failure.

Early detection of a problem in the hospital and consequent treatment is essential. Hospital cardiac patient monitoring technology is a vital aid in providing that treatment. Hospitals and clinicians have increased access to devices in every department of the hospital and during transport as insurers realize the value of detecting and treating cardiac symptoms as they occur, rather than waiting until the patient condition has deteriorated. .

Cardiac patient monitoring is evolving as systems become smaller and offer more functionality. Cardiac patient monitoring market driving forces still relate to reimbursement by CMS and private insurance carriers in the US and by nationalized systems in other places. The principal competitive factors that impact the success of cardiac monitoring solutions include the parameters discussed in the market research study:

According to lead author who have prepared the Hospital Patient Multi -Parameter Monitors market research study, "Hospital cardiac patient monitoring technology companies are struggling to achieve a focus on health delivery and well-being initiatives. Vendors strive for a balanced portfolio of businesses that can attain global leadership positions. Vendors seek to deliver performance above benchmark levels. Challenges are influencing hospital cardiac patient monitoring business activities"

When chronic disease conditions are treated early on when there is an early change in patient condition an early intervention can make a difference. It is even better to treat patients in a wellness treatment environment before there are indications of chronic disease, before symptoms develop, by addressing lifestyle issues early on.

Global hospital cardiac patient monitoring devices market at $3.8 billion in 2012 is forecast to reach at $5.3 billion by 2019 at a growth rate of 5.5% during the analysis period. Growth continues as market penetration into all areas of the hospital expands. The installed base continues to grow as replacement of units is stretched to 12 years and beyond.

For more information visit : http://www.marketresearchreports.com/wintergreen-research/hospital-patient-multi-parameter-monitors-market-shares-strategies-and

Find all Pharmaceuticals and Healthcare Reports under a single page.

MarketResearchReports.com: Telemedicine push to talk PTT markets to reach $4.4 billion by 2019 Reveals New Report

The report has 791 pages, 278 tables and figures. Worldwide markets are poised to achieve significant growth as the push to talk is used inside telemedicine systems and m-health initiatives as a way to implement ruggedized handset communications for all clinicians.

Worldwide Tele-medicine and M-health PTT push to talk device market driving forces relate to an overall trend toward clinical reimbursement addressing mobile health initiative for chronic conditions. This trend promises to become prevalent as people learn how to keep themselves healthier. Healthy behaviors such as exercise, good diet and stress management have the potential to reverse aging on a molecular level and partly restore the vitality of a person's cells.

Healthy lifestyle choices can increase the length of DNA sequences found at the end of a person's chromosomes. This shift toward wellness has stimulated the need for better communication between clinicians and patients. New sensor technology creates the opportunity for monitoring and for alerts to be send to and from at risk people who are exercising.

PTT telemedicine markets are poised to achieve significant growth as the existing telemedicine systems merge with the smart phone systems of engagement to provide a way to improve clinical care delivery to patients with chronic disease, decreasing hospitalizations and visits to the emergency room. There is a convergence of telemedicine and m-health as the patients become more responsible for their own care delivery and their own health.

There is a convergence of telemedicine and m-health as the patient uses push to talk devices in telemonitoring situations where the sensor data is transmitted to a facility, encouraging the patient to become more responsible for their own care delivery and their own health. Push to talk devices are more rugged than ordinary smart phones and are used in transport situations inside the hospital and in ambulances.

Healthcare patient, physician, and facility decision support markets are forecast based n the broad availability of smartphones combined with the IBM Watson technology that Watson offers Interactive Care Insights for Oncology. The cognitive systems use insights gleaned from the deep experience of Memorial Sloan-Kettering clinicians. Watson is positioned to permit clinicians to provide individualized treatment.

According to Susan Eustis, lead author of the Publisher Research team that prepared the telemedicine market research study, "Telemedicine push to talk PTT markets are evolving as smart phone devices find more uses during patient transport. During emergency transport, sensors can provide monitoring that has not previously been available. Differential diagnostic tools support differential tele-medical treatment. The decision process take into account clinical findings form the home monitoring devices and from symptoms verbally communicated in a clinical services implementation."

Both tele-medicine and m-health contribute to healthcare delivery in the home. M-health will surely be delivered over the smart phone. Tele-medicine is evolving toward smart phone device delivery as well. 

The cost of tele-medicine for the US veterans administration is $1,600 per patient per annum. This is substantially less than other NIC programs and nursing home care which can easily run to $100,000 per annum. VHA's experience is that an enterprise-wide home tele-medicine implementation is an appropriate and cost-effective way of managing chronic care patients in both urban and rural settings.

Chronic disease conditions are best treated early on when there is a change in patient condition and an early intervention can make a difference. It is even better to treat them in a wellness treatment environment before there are indications of chronic disease, before symptoms develop, by addressing lifestyle issues early on.

Telemedicine delivered on proprietary devices is becoming obsolete. Kyocera is the market leader in push to talk phones for telemedicine. The Honeywell / Samsung strategic alliance represents the smart phone model that works. Telemedicine market analysis indicates that the price points are way below device costs and that companies are seeking to gain market share by working with clients.

Telemedicine push to talk PTT dedicated device and software markets at $214 million in 2012 are anticipated to reach $4.4 billion by 2019. M-Health markets related to telemedicine at $1.4 billion are anticipated to reach $1.5 trillion by 2019 due to the leveraging of 8.5 billion smart phones and 5 billion connected tablet devices all over the world.

For more information visit : http://www.marketresearchreports.com/wintergreen-research/push-talk-telemedicine-and-m-health-convergence-market-shares-strategies-and

Find all Pharmaceuticals and Healthcare Reports under a single page.

MarketResearchReports.com: Coronary Stents Market in India 2013, New Report Launched

Coronary stents Market in India 2013 report states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the number of cath labs in the country and their subsequent expansion to smaller cities and towns, angioplasties will become more accessible to patients and will aid in further development of the market.

Products available in the market can be divided into two types – those manufactured by MNCs that command high prices, and those manufactured by domestic companies that are generally priced lower.  It is the MNCs that serve the majority of the market with almost all the big hospitals in tier I cities, where most of the angioplasties are performed, preferring to implant stents manufactured by foreign companies over those manufactured by their Indian counterparts. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy, whereas those manufactured by domestic companies fail to attain similar high standards of quality. Also, patients are generally unaware of the choices they have in terms of the types of stents and the various brands that are available in the market, and have to buy stents directly from the hospitals. Since profit margins are higher in case of foreign-manufactured stents, hospitals push for the sale of such stents rather than selling the Indian varieties.

Since the medical equipment and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 has come as a body blow to manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower prices in the open market as well. The Drugs and Cosmetics (Amendment) Bill, 2013 was presented before the Parliament of India in August 2013 and if the Bill is passed, it will provide the growing medical devices sector an impetus in the form of a much needed regulatory mechanism and will benefit the coronary stents market as well.

Spanning over 134 pages and 30 figures, “Coronary Stents Market in India 2013” report provide operator strategy, business development and/or corporate development team.

In addition to covering the Overview of Macroeconomic Indicators, Introduction, Market Overview, Drivers & Challenges, Government Involvement, Competitive Landscape, Buyer Details, Recent Developments, Strategic Recommendation, Appendix. The report cover 1 Public Companies & 9 Private Companies- Opto Circuits (India) Ltd., Abbott Healthcare Pvt. Ltd., B. Braun Medical (India) Pvt. Ltd., Boston Scientific India Pvt. Ltd., India Medtronic Pvt. Ltd.,MIV, Meril Life Sciences Pvt. Ltd., Relisys Medical Devices Ltd., Sahajanand Medical Technologies Pvt. Ltd., Vascular Concepts Ltd.

For more information visit : http://www.marketresearchreports.com/netscribes-india-pvt-ltd/coronary-stents-market-india-2013

Find all Pharma and Healthcare reports under a single page

MarketResearchReports.com: PharmaPoint: Meningococcal Vaccines - Current and Future Players, New Report Launched

Publisher has released its pharma report, “PharmaPoint: Meningococcal Vaccines - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Meningococcal Vaccines Market. The report identifies and analyses the key companies shaping and driving the global Meningococcal Vaccines market. The report provides insight into the competitive Meningococcal Vaccines landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

• Investigation of current and future market competition for Meningococcal Vaccines
• Competitor assessment
• Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
• Strategic assessment of the Meningococcal Vaccines sector through market impact analysis, future market scenario and company analysis

Reasons to buy

• Gain a high level view of the trends shaping and driving the Meningococcal Vaccines Market
• Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
• Create an effective counter-strategy to gain a competitive advantage against those currently in the market
• What’s the next big thing in the global Meningococcal Vaccines market landscape? Identify, understand and capitalize

Spanning over 70 pages, 17 tables and 2 figures, “PharmaPoint: Meningococcal Vaccines - Current and Future Players” report includes Market Outlook, Current and Future Players, Trends in Corporate Strategy, Company Profiles. . The report cover 6 companies -  Sanofi, Novartis, GlaxoSmithKline, Baxter, Nuron Biotech, Pfizer.

For more information visit: http://www.marketresearchreports.com/globaldata/pharmapoint-meningococcal-vaccines-current-and-future-players

Find all Medical Diseases reports under a single page

MarketResearchReports.com: MediPoint: Hernia Repair - Current and Future Players, New Report Launched

Dramatic improvements in access to and quality of healthcare in the Asia Pacific region, concurrent with the introduction of next-generation biologic and composite meshes in developed countries and adoption of laparoscopic techniques worldwide, will drive hernia repair market growth in the US, Europe and Asia Pacific. Saturated with numerous players and a library of different products, the fiercely-competitive hernia mesh industry has experienced notable improvements recently in device quality and affordability, as companies strive for increased physician adoption in established markets and strategize entry into new regions.

The report identifies and analyzes the key companies shaping and driving the global hernia repair market. The report provides insight into the competitive hernia repair landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading surgeons, with in-house analysis conducted by GlobalData’s team of industry experts.

Scope

• Investigation of current and future market competition for hernia repair
• Competitor assessment including device approval analysis.
• Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
• Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
• Direct quotes from Key Opinion Leaders (KOL) as well as surgeons using hernia repair devices in clinical practice.

Reasons to buy

• Gain a high level view of the trends shaping and driving the hernia repair market for coronary applications and peripheral applications in the lower extremity.
• Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
• Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
• Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
• Create an effective counter-strategy to gain a competitive advantage against those currently in the market.

Spanning over 166 pages, 92 tables and 60 figures, “MediPoint: Hernia Repair - Current and Future Players” report includes Competitive Assessment, Pipeline Products, Current and Future Players. The report cover 15 companies -  Abiss Analytic Biosurgical Solutions, AMI: Agency for Medical Innovation, Angiologica, Aspide Medical, Assut Europe, Atrium Medical, B. Braun Surgical, Cook Medical, Cousin Biotech, Covidien, C.R. Bard, Ethicon, FEG Textiltechnik mbH, Proxy Biomedical, TEI Bioscienc.

For more information visit: http://www.marketresearchreports.com/globaldata/medipoint-hernia-repair-current-and-future-players

Find all Pharmaceuticals and Healthcare reports under a single page

MarketResearchReports.com: U.S. Markets for Anesthesia, Respiratory and Sleep Management Devices, New Report Launched

The U.S. market for anesthesia, respiratory and sleep management devices is showing signs of sustained recovery, with particularly strong growth in sleep and oxygen therapy markets.

This market includes anesthesia delivery units, anesthesia monitors, anesthesia information management systems, anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy equipment, sleep therapy devices and sleep diagnostic devices. Dominated in value by the market for sleep therapy devices, the U.S. market for anesthesia, respiratory and sleep management devices is expected to accelerate and maintain strong growth over the forecast period.

Scope: This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment & Country
• Trend Analysis by Segment & Country
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Main Markets Included:

• Anesthesia Delivery Units
• Anesthesia Monitors
• Anesthesia Information Management Systems
• Anesthesia Disposables
• Ventilators
• Nebulizers
• Respiratory Disposables
• Oxygen Therapy
• Therapeutic Obstructive Sleep Apnea Devices
• Sleep Diagnostic Devices

Sub-Segments Included:

• Hospital OR ADU (High complexity and low complexity)
• Other hospital suite (MRI, Obstetrics and Other) ADU
• Hospital Preoperative Anesthesia Monitors
• Hospital Operating Room Anesthesia Monitors
• Hospital Post-Anesthesia Care Unit Anesthesia Monitors
• Hospital Obstetric Anesthesia Monitors
• ASC Preoperative Anesthesia Monitors
• ASC Operating Room Anesthesia Monitors
• ASC Post-Anesthesia Care Unit Anesthesia Monitors
• Hospital AIMS
• ASC AIMS
• Anesthesia Circuit Market
• Anesthesia Mask Market
• Endotracheal Tube Market Laryngeal Mask Market (Disposable and Reusable)
• Acute-Care Ventilators
• Sub-Acute Ventilators
• Home-Care Ventilators
• Neo-Natal Ventilators
• Non-Invasive Ventilators
• Stationary Compressor/Jet Nebulizer Market
• Portable Compressor/Jet Nebulizer Market
• Ultrasonic Nebulizer Market
• Vibrating Mesh Market
• Oxygen Cannula Market
• Oxygen Mask Market
• Tracheostomy Tube Market
• Resuscitator Market
• Stationary Oxygen Concentrator Market (Standard and High-Flow)
• Ambulatory Oxygen Concentrator Market (Transportable and Portable)
• Transfilling Device Market
• Aluminum Medical Oxygen Cylinder Market (Ambulatory and Back-up)
• Medical Oxygen Regulator Home Care Market
• Oxygen Conserver Market (Pneumatic and Electronic)
• Continuous Positive Airway Pressure (CPAP) Device Market
• Auto-Titrating Positive Airway Pressure (APAP) Device Market
• Bi-Level Positive Airway Pressure Device Market
• Sleep Therapy Interface Market
• Nasal Mask Market
• Full-Face Mask Market
• Nasal Pillow/Alternative Interface Market

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

Spanning over 242 pages, “Chinese Market for Neurological Devices” report includes U.S. Anesthesia, Respiratory and Sleep Management Device Market, Anesthesia Delivery Unit Market, Anesthesia Monitor Market, Anesthesia Information Management System Market, Anesthesia Disposables Market, Ventilator Market, Nebulizer Market, Respiratory Disposables Market, Oxygen Therapy Market, Therapeutic Obstructive Sleep Apnea Device Market, Sleep Diagnostic Device Market.

For more information visit: http://www.marketresearchreports.com/idata-research/us-markets-anesthesia-respiratory-and-sleep-management-devices

Find all Medical devices reports under a single page

MarketResearchReports.com: Chinese Market for Neurological Devices, New Report Launched

The Chinese market for neurological devices includes fixed pressure CSF shunts, adjustable pressure CSF shunts, bare platinum detachable coils, coated detachable coils, liquid embolics, neurovascular catheters, neurovascular stents, neurovascular guide wires, deep brain stimulators (DBS), spinal cord stimulators (SCS), sacral nerve stimulators (SNS), intrathecal pumps, frame-based stereotactic systems, frameless stereotactic systems and aneurysm clips.

Market growth will be driven by the continued acceptance of aneurysm treatment procedures, arteriovenous malformation (AVM) treatment procedures and frameless stereotactic treatment for cranial tumors.

Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for China.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment
• Trend Analysis by Segment
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Main Segments Included:

• Detachable Coil Market
• Liquid Embolics Market
• Neurovascular Stent Market
• Neurovascular Catheter Market
• Neurovascular Guidewire Market
• Neuromodulator Market
• Stereotactic System Market
• Aneurysm Clip Market
• Cerebrospinal Fluid Shunt Market
• Emerging Market: Ultrasonic Aspirator Market
• Emerging Market: Transcranial Magnetic Stimulator Market
• Emerging Market: Intracranial Pressure Monitoring Device Market

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

Spanning over 242 pages, “Chinese Market for Neurological Devices” report includes Chinese Neurological Device Market, Neurological Procedures, Cerebrospinal Fluid Shunt Market, Detachable Coil Market, Liquid Embolics Market, Neurovascular Stent Market, Neurovascular Catheter Market, Neurovascular Guidewire Market, Neuromodulation Market, Stereotactic System Market, Aneurysm Clip Market, Emerging Market: Ultrasonic Aspirator Market, Emerging Market: Transcranial Magnetic Stimulator Market, Emerging Market: Intracranial Pressure Monitoring Device Market, Appendix: Neuroendoscope Market.

For more information visit: http://www.marketresearchreports.com/idata-research/chinese-market-neurological-devices

Find all Pharmaceuticals and Healthcare reports under a single page

MarketResearchReports.com: MediPoint: Trauma Fixation - EU Analysis and Market Forecasts, New Report Launched

Traumatic injury patients that come into the Emergency Room (ER) experience orthopedic injury in the form of fractures 60% to 65% of the time, based on publisher conversations with key opinion leaders. Of this population, 45%–50% are operable and require fracture repair techniques in the form of external or internal fixation. As the global population continues to grow in the emerging markets, with overcrowding and economic growth, some of the drivers for trauma fixation include motor vehicle accidents and aging. Publisher analysis shows that while the orthopedics implant market is mature, where products have become commodities, trauma fixation is one that has room for more technological development and adoption.

The EU market is an unsure market with regards to high growth in trauma fixation. There is a strong dependence on reimbursement which can vary between nations. Moving forward publisher believes that the most growth will continue to be IM nails, due to the minimally invasive approach they have compared with other systems.

Scope

• An overview of bone trauma, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
• Annualized EU trauma fixation market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.
• Investigation of current and future market competition for trauma fixation
• Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
• Competitor assessment including device approval analysis and device sales forecasts.
• Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
• Analysis of unmet needs within the market and opportunities for future players.
• Technology trends evaluation to assess strength of pipeline.
• An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
• Company profiles including business description, financial overview and SWOT analysis.
• Coverage of key market players.
• Strategic assessment of the trauma fixation sector through market impact analysis, future market scenario and company analysis.
• Direct quotes from Key Opinion Leaders (KOL) as well as Orthopedic Surgeons.

Reasons to buy

• Understand the trends shaping and driving the EU trauma fixation Market.
• Realize device preferences of physicians who have performed the tests already.
• Access market sizing, forecasts and quantified growth opportunities in the EU trauma fixation market through 2018.
• Quantify candidate patient populations to better design product pricing & launch plans.
• Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
• Perform benchmarking analysis of growth opportunities against currently marketed products.
• Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
• Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
• Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
• Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
• What’s the next big thing in EU trauma fixation market landscape? Identify, understand and capitalize.

Spanning over 198 pages, 104 tables and 33 figures, “MediPoint: Trauma Fixation - EU Analysis and Market Forecasts” report includes Disease Overview, Industry Overview, Competitive Assessment, Unmet Needs, Pipeline Products, Clinical Trials to Watch, Current and Future Players, Market Outlook. The report cover 13 Companies- Acumed, Biomet, DePuy Synthes International, Integra LifeSciences, Orthofix, OsteoMed, Small Bone Innovations, Inc., Smith & Nephew, Stryker, Tornier, Trimed Inc., Wright Medical, Zimmer.

For more information visit: http://www.marketresearchreports.com/globaldata/medipoint-trauma-fixation-eu-analysis-and-market-forecasts

MarketResearchReports.com: MediPoint: Drug-Eluting Balloons - US Analysis and Market Forecast, New Report Launched

MediPoint: Drug-Eluting Balloons - US Analysis and Market Forecasts report is an essential source of information and analysis on the drug-eluting balloons (DEB) market in the US. The report provides in-depth insight into the use of DEB for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal artery and below-the-knee lesions, chronic total occlusions, acute myocardial infarction and lesions in diabetics.

The DEB market in the US was assessed to identify the unmet needs in the market, understand the regulatory challenges DEB manufacturers will encounter in the US, identify the challenges to adoption in clinical practice and evaluate future adoption of DEB for select coronary and peripheral indications. The US sales expectations are discussed through careful analysis of adoption patterns of using DEB.

Clients can use this report to better understand the scope of this technology and for strategic planning to explore opportunities in this dynamic market. The report provides insights into the competitive landscape, the marketed and pipeline DEB products, the current and emerging players and comparative market analysis of different types of interventional techniques used to treat coronary and peripheral artery disease. This report is built using data and information sourced from secondary sources and primary research interviews and survey with leading Interventional Cardiologists and Interventional Radiologists, with in-house analysis conducted by GlobalData’s team of industry experts.

Scope

• An overview of coronary artery disease and peripheral artery disease in the lower extremity, which includes epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.
• Annualized total drug-eluting balloon market revenue by type of disease, annual cost of disease and drug-eluting balloons adoption pattern and procedure data in the US from 2010-2012 and forecast for seven years to 2019.
• Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access and implications of the drug-eluting balloon market.
• Pipeline analysis: comprehensive data split across different stages of development, emerging trends and DEB designs in development, including investigation of DEB coating technology, antiproliferative agent used, balloon and catheter design and durability.
• Analysis of the current and future market competition in the US drug-eluting balloon market. Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy-

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends that will shape and drive the DEB market in the US.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the US DEB market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the US DEB market by disease and indication from 2010-2019.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Spanning over 377 pages, 142 tables and 41 figures, “MediPoint: Drug-Eluting Balloons - US Analysis and Market Forecasts” report includes Disease Overview, Competitive Assessment, Unmet Needs, Pipeline Products, Clinical Trial Analysis, Industry Overview, Current and Future Players, Market Drivers, Opportunities, Barriers and Substitutes, Drug-Eluting Balloon Market Analysis, Country Outlooks & Forecasts. For more information visit: http://www.marketresearchreports.com/globaldata/medipoint-drug-eluting-balloons-us-analysis-and-market-forecasts

The report cover 17 companies - Aachen Resonance, AnGes MG, AngioScore, AVIDAL Vascular, B. Braun, Biosensors International, Biotronik, Blue Medical, Boston Scientific Corporation, Caliber Therapeutics, Cardionovum, Concept Medical Research, Cook Medical, Covidien, C.R. Bard, DSM Biomedical, Elixir Med.

Find all Pharmaceuticals and Healthcare reports under a single page